| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.25 | 0.005 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.41 | 0.005 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.2 | 0.006 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.006 |